| Rachel A Stucky, PA | |
|
1000 Hospital Dr, Mcpherson, KS 67460-2326 | |
| (620) 241-7400 | |
| (620) 798-2613 |
| Full Name | Rachel A Stucky |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 1000 Hospital Dr, Mcpherson, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356305759 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AM0700X | Physician Assistant - Medical | 15-01013 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rachel A Stucky, PA 1000 Hospital Dr, Mcpherson, KS 67460-2326 Ph: (620) 241-7400 | Rachel A Stucky, PA 1000 Hospital Dr, Mcpherson, KS 67460-2326 Ph: (620) 241-7400 |
News Archive
People with diabetes often suffer from wounds that are slow to heal and can lead to ulcers, gangrene and amputation. New research from an international group led by Min Zhao, professor of ophthalmology and of dermatology at the University of California, Davis, shows that, in animal models of diabetes, slow healing is associated with weaker electrical currents in wounds.
Incidence rates of skin cancer (cutaneous malignant melanoma) have increased more than 550% in males and 250% in females since the early 1980s in England - according to a new study by Brighton and Sussex Medical School (BSMS).
A new analysis finds that compared to Caucasians, African-Americans with systemic scleroderma have more antibodies in the blood that are linked to severe complications and an increased likelihood of death. They say this finding, published today in Arthritis & Rheumatism, suggests physicians can use these disease markers to screen and treat scleroderma patients proactively.
Neurocrine Biosciences, Inc. announced today that NBI-98854, a highly selective small molecule VMAT2 inhibitor, showed a statistically significant reduction in tardive dyskinesia during the six weeks of placebo-controlled treatment in the Kinect 3 clinical trial. This Phase III trial included moderate to severe tardive dyskinesia patients with underlying schizophrenia, schizoaffective disorder, bipolar or major depressive disorder.
› Verified 4 days ago
Jill Raelynn Sigsbee, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1000 Hospital Dr, Mcpherson, KS 67460 Phone: 620-241-7400 Fax: 620-798-2613 | |
Nicholas L Vogts, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1000 Hospital Dr, Mcpherson, KS 67460 Phone: 620-241-7400 Fax: 620-798-2613 | |
Mary Ann Carlson, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1102 Hospital Drive, Mcpherson, KS 67460 Phone: 620-245-5000 Fax: 620-245-5099 | |
Mrs. Melisa Dawn Cooper, MMS, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1000 Hospital Dr, Mcpherson, KS 67460 Phone: 620-241-7400 Fax: 620-798-2613 | |
Mr. Eric Michael Jusko, Physician Assistant Medicare: Medicare Enrolled Practice Location: 1509 N Walnut St, Mcpherson, KS 67460 Phone: 818-303-5524 | |
Brent Roberts, RPH Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 205 S Centennial Dr, Mcpherson, KS 67460 Phone: 620-241-0941 |